Showing results (21-30 of 46) with videos related to
Sort By:
Pageof 5
Respirology Case Reports|February 21, 2024
Interstitial lung changes and persistent COVID-19 in a patient with follicular lymphoma: A case reportMakiko Yomota, Masaru Tanaka, Takayuki Kobayashi, et al.Lung Cancer (Amsterdam, Netherlands)|June 12, 2019
Nivolumab for advanced non-small cell lung cancer patients with mild idiopathic interstitial pneumonia: A multicenter, open-label single-arm phase II trialDaichi Fujimoto, Makiko Yomota, Akimasa Sekine, et al.Internal Medicine (Tokyo, Japan)|February 12, 2024
Real-world Prognostic Data on Unresectable Stage III Non-small-cell Lung Cancer Treated with Concurrent Chemoradiation Therapy by Histological TypeKazutoshi Toriyama, Makiko Yomota, Maiko Asai, et al.Nihon Kokyuki Gakkai Zasshi = the Journal of the Japanese Respiratory Society|August 15, 2008
[A case of bird related hypersensitivity pneumonitis had a progressive course]Ayumi Kohno, Tatsuji Enomoto, Kazuyo Kaneko, et al.Immunotherapy|February 8, 2019
Management of cardiac tamponade during nivolumab of lung cancer with intrapericardial bleomycin: case reportMaiko Asai, Yasuhiro Kato, Shoko Kawai, et al.Translational Lung Cancer Research|March 14, 2022
Association between the baseline tumor size and outcomes of patients with non-small cell lung cancer treated with first-line immune checkpoint inhibitor monotherapy or in combination with chemotherapyYuji Uehara, Taiki Hakozaki, Rui Kitadai, et al.Oncotargets and Therapy|September 30, 2024
Case Report: Structurally Rare EML4-ALK Identified by Next Generation Sequencing in a Patient with NSCLC with Bilateral Ovarian MetastasesRyusuke Maruta, Daichi Sadato, Makiko Yomota, et al.Journal of Thoracic Disease|August 3, 2019
Impact of clinical features on the efficacy of osimertinib therapy in patients with T790M-positive non-small cell lung cancer and acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitorsYasuhiro Kato, Yukio Hosomi, Kageaki Watanabe, et al.Anticancer Research|January 29, 2018
Association Between Clinicopathological Features and Programmed Death Ligand 1 Expression in Non-small Cell Lung CancerYasuhiro Kato, Jumpei Kashima, Kageaki Watanabe, et al.Japanese Journal of Infectious Diseases|May 6, 2021
Number of Patients with Influenza and COVID-19 Coinfection in a Single Japanese Hospital during the First WaveShoko Kawai, Kazuaki Fukushima, Makiko Yomota, et al.Pageof 5